SUMMARY HIV‐1 and HIV‐2 share many similarities including their basic gene
arrangement, modes of transmission, intracellular replication pathways and clinical …

Infection with human immunodeficiency virus type 2 (HIV-2) occurs mainly in West Africa, but
an increasing number of cases have been recognized in Europe, India, and the United …

Abstract The Simian Immunodeficiency Virus of sooty mangabeys (SIVsmm) has been
revealed to be at the origin of Human Immunodeficiency Virus type 2 (HIV-2) in humans …

Distinct from HIV-1 and often neglected in the global campaign to end the AIDS epidemic,
HIV-2 presents unique and underappreciated challenges in diagnosis, clinical care …

Summary Background HIV type 2 (HIV-2) is considered more benign and has fewer
pathogenic consequences than HIV type 1 (HIV-1) for most infected individuals. However …

Background CD8+ T cells equipped with a full arsenal of antiviral effector functions are
critical for effective immune control of HIV-1. It has nonetheless remained unclear how best …

Two HIV virus types exist: HIV-1 is pandemic and aggressive, whereas HIV-2 is confined
mainly to West Africa and less pathogenic. Despite the fact that it has been almost 40 years …

People living with HIV-2 initiate ART later than HIV-1 and HIV duals, resulting in higher
disease progression and mortality rate. The clinical management of HIV-2 infected patients …

Human immunodeficiency virus (HIV) is the causative agent of acquired immunodeficiency
syndrome (AIDS). The two main forms of HIV are HIV-1 and HIV-2; in the clinic, each is …

Retroviruses are genome invaders that have shared a long history of coevolution with
vertebrates and their immune system. Found endogenously in genomes as traces of past …